Importance Many patients with nonvalvular atrial fibrillation (NVAF) are at a high risk of
gastrointestinal (GI) bleeding due to conditions including older age; stage III to V chronic …

Over the past few decades, a series of innovative medicines have been developed in order
to optimize anticoagulation therapy for atrial fibrillation (AF). As a result, a number of …

Aims: To assess the impact of anticoagulant treatment, on risk for stroke and all-cause
mortality of patients with atrial fibrillation, using real world data. Methods: Patients with …

Purpose The risk of gastrointestinal bleeding (GIB) can be mitigated by proton pump
inhibitor (PPI) co-therapy in patients with atrial fibrillation (AF) treated with anticoagulants …

Ethnopharmacological relevance The adverse effects of Fructus Psoraleae (FP), especially
liver injury, have attracted wide attention in recent years. Aim of the study To establish a …

The objective is to assess the impact of anticoagulant treatment in non-valvular atrial
fibrillation (AF) and different categories of renal dysfunction in real world. Electronic Health …

Proton pump inhibitors (PPIs) can reduce the risk of upper gastrointestinal bleeding (UGIB)
in patients who are taking oral anticoagulants. This study aimed to identify the association …

Background Bleeding is a serious adverse effect of vitamin K antagonists (VKAs).
Anticoagulation reversal is required in some acute cases. This is usually accomplished by …

Die Kapselendoskopie (KE) ist die Standardmethode zur Diagnostik mittlerer
gastrointestinaler Blutungen. Am Universitätsklinikum Ulm zeigte sich eine deutliche …

Background: Non-valvular atrial fibrillation (NVAF) is associated with ischemic stroke risk in
the aging population. Observational studies have indicated beneficial effects of direct-acting …